Abstract: The present invention provides a diagnostic rescue of silent scalp swelling by fine-needle aspiration. The silent RCC may primarily present as cutaneous metastasis, and therefore, every skin swelling should also be evaluated in light of the presence of any occult primary. FNAC may prove to be an important diagnostic tool for evaluating such cutaneous metastasis. Vigilant examination of cytological smears will be helpful in clinging precise diagnosis even in unsuspected cases. The early diagnosis will thus prevent delay in treatment and further complications. Our case presented as cutaneous metastasis in the scalp with no associated abdominal signs or symptoms of RCC such as abdominal lump, hematuria, or other urinary symptoms. The present case which is clinically suspected to be an abscess or adnexal tumor scalp turned out to be metastatic RCC on FNAC.
FIELD OF THE INVENTION
[001] The present invention relates to the field of medical science, and more particularly,
the present invention relates to the diagnostic rescue of silent scalp swelling by fine-needle
aspiration.
BACKGROUND FOR THE INVENTION:
[002] The following discussion of the background of the invention is intended to facilitate an understanding of the present invention. However, it should be appreciated that the discussion is not an acknowledgment or admission that any of the material referred to is published, known, or part of the common general knowledge in any jurisdiction as of the priority date of the application. The details provided herein the background if belongs to any publication is taken only as a reference for describing the problems, in general terminologies or principles or both of science and technology in the associated prior art.
[003] RCC commonly metastasizes to the lung, lymph nodes, bone, adrenals, and brain. Cutaneous metastases are considered to be rare and present in only 1%–3.3% of RCC cases. It is even more uncommon to find cutaneous metastases as the primary manifestation of silent RCC. The common sites of RCC cutaneous metastases which have been reported by a handful of cases reports in the literature are the toe, head and neck, and scrotum. RCC develops metastasis in 25% of cases at the time of diagnosis or during follow-up.
[004] The available diagnosticmethods are not economical, accurate, and time efficient. Further, the available diagnosticmethods are user-friendly and friendly as these diagnosticmethods take time to respond. Some of the diagnosticmethods are not effectively used for remote locations. Also, the available diagnosticmethods are provided with the wrong information, which may mislead the user.
[005] Although there are a number of solutions in the form of diagnosticmethods, none of them are specially designed with an accurate diagnosis. Although some of the prior existing solutions attempt to create reliable and economical diagnosticmethods, this solution fails to meet the user’s requirements. In view of the above prior art, it can be understood that many diagnosticmethods have been designed in an attempt to provide similar solutions, however, they are bulky, expensive, and inefficient.
[006] In light of the foregoing, there is a need for the diagnostic rescue of silent scalp swelling by fine-needle aspirationthat overcomes problems prevalent in the prior art.
We Claim:
1) A diagnostic rescue of silent scalp swelling by fine-needle aspiration, wherein the silentRCC is primarily present as cutaneous metastasis, and therefore, every skin swelling should also be evaluated inlight of the presence of any occult primary.
2) The diagnostic rescue as claimed in claim 1, wherein FNAC is proved an important diagnostic tool for evaluating suchcutaneous metastasis.
3) The diagnostic rescue as claimed in claim 1, wherein vigilant examination of cytological smears will be helpful in clinging precise diagnosis even inunsuspected cases.
4) The diagnostic rescue as claimed in claim 1, wherein the early diagnosis prevents delay in treatment and further complications.
5) The diagnostic rescue as claimed in claim 1, wherein the cutaneous metastasis of RCC is associated with poor prognosis, and life expectancy is usually about 6 months.
6) The diagnostic rescue as claimed in claim 1, wherein the patient is survived for 2 years after the initial cutaneous manifestation and is subjected to palliativeradiotherapy due to early diagnosis followed by appropriate treatment.
| # | Name | Date |
|---|---|---|
| 1 | 202211063252-FORM 18 [17-10-2023(online)].pdf | 2023-10-17 |
| 1 | 202211063252-STATEMENT OF UNDERTAKING (FORM 3) [05-11-2022(online)].pdf | 2022-11-05 |
| 2 | 202211063252-REQUEST FOR EARLY PUBLICATION(FORM-9) [05-11-2022(online)].pdf | 2022-11-05 |
| 2 | 202211063252-COMPLETE SPECIFICATION [05-11-2022(online)].pdf | 2022-11-05 |
| 3 | 202211063252-DECLARATION OF INVENTORSHIP (FORM 5) [05-11-2022(online)].pdf | 2022-11-05 |
| 3 | 202211063252-POWER OF AUTHORITY [05-11-2022(online)].pdf | 2022-11-05 |
| 4 | 202211063252-FORM-9 [05-11-2022(online)].pdf | 2022-11-05 |
| 4 | 202211063252-DRAWINGS [05-11-2022(online)].pdf | 2022-11-05 |
| 5 | 202211063252-FORM FOR SMALL ENTITY(FORM-28) [05-11-2022(online)].pdf | 2022-11-05 |
| 5 | 202211063252-EDUCATIONAL INSTITUTION(S) [05-11-2022(online)].pdf | 2022-11-05 |
| 6 | 202211063252-FORM 1 [05-11-2022(online)].pdf | 2022-11-05 |
| 6 | 202211063252-EVIDENCE FOR REGISTRATION UNDER SSI [05-11-2022(online)].pdf | 2022-11-05 |
| 7 | 202211063252-FIGURE OF ABSTRACT [05-11-2022(online)].pdf | 2022-11-05 |
| 7 | 202211063252-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [05-11-2022(online)].pdf | 2022-11-05 |
| 8 | 202211063252-FIGURE OF ABSTRACT [05-11-2022(online)].pdf | 2022-11-05 |
| 8 | 202211063252-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [05-11-2022(online)].pdf | 2022-11-05 |
| 9 | 202211063252-FORM 1 [05-11-2022(online)].pdf | 2022-11-05 |
| 9 | 202211063252-EVIDENCE FOR REGISTRATION UNDER SSI [05-11-2022(online)].pdf | 2022-11-05 |
| 10 | 202211063252-EDUCATIONAL INSTITUTION(S) [05-11-2022(online)].pdf | 2022-11-05 |
| 10 | 202211063252-FORM FOR SMALL ENTITY(FORM-28) [05-11-2022(online)].pdf | 2022-11-05 |
| 11 | 202211063252-FORM-9 [05-11-2022(online)].pdf | 2022-11-05 |
| 11 | 202211063252-DRAWINGS [05-11-2022(online)].pdf | 2022-11-05 |
| 12 | 202211063252-POWER OF AUTHORITY [05-11-2022(online)].pdf | 2022-11-05 |
| 12 | 202211063252-DECLARATION OF INVENTORSHIP (FORM 5) [05-11-2022(online)].pdf | 2022-11-05 |
| 13 | 202211063252-REQUEST FOR EARLY PUBLICATION(FORM-9) [05-11-2022(online)].pdf | 2022-11-05 |
| 13 | 202211063252-COMPLETE SPECIFICATION [05-11-2022(online)].pdf | 2022-11-05 |
| 14 | 202211063252-STATEMENT OF UNDERTAKING (FORM 3) [05-11-2022(online)].pdf | 2022-11-05 |
| 14 | 202211063252-FORM 18 [17-10-2023(online)].pdf | 2023-10-17 |
| 15 | 202211063252-FER.pdf | 2025-06-20 |
| 16 | 202211063252-FER_SER_REPLY [11-07-2025(online)].pdf | 2025-07-11 |
| 1 | 202211063252_SearchStrategyNew_E_SearchStrategy202211063252E_20-06-2025.pdf |
| 2 | 202211063252_SearchStrategyAmended_E_202211063252SERSearchStrategyAE_19-08-2025.pdf |